
Results
25
Most Popular Stocks on the market
25 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł20.40
7D
8.4%
1Y
-23.2%
Selvita
Market Cap: zł811.3m
Operates as a contract research organization worldwide.
SLV
zł44.20
7D
8.1%
1Y
-11.1%
Ryvu Therapeutics
Market Cap: zł627.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł27.15
7D
7.1%
1Y
-30.1%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł414.7m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł75.00
7D
7.4%
1Y
66.7%
Bioceltix
Market Cap: zł396.4m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł80.50
7D
0.6%
1Y
-8.1%
BIOTON
Market Cap: zł339.2m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.95
7D
5.1%
1Y
25.0%
Synthaverse
Market Cap: zł271.4m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł3.84
7D
8.6%
1Y
-14.2%
Molecure
Market Cap: zł135.2m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł6.56
7D
3.1%
1Y
-33.1%
Poltreg
Market Cap: zł118.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł25.50
7D
3.7%
1Y
-37.7%
Mabion
Market Cap: zł117.8m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł7.29
7D
4.9%
1Y
-28.2%
NanoGroup
Market Cap: zł86.2m
Operates as a biotechnology company in Poland.
NNG
zł2.68
7D
3.1%
1Y
-20.2%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Read-Gene
Market Cap: zł64.4m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł5.46
7D
-0.7%
1Y
8.3%
Urteste
Market Cap: zł59.9m
Engages in the research and development of diagnostic tests for cancers.
URT
zł42.50
7D
6.3%
1Y
-57.1%
Genomtec
Market Cap: zł56.8m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł3.77
7D
0%
1Y
-51.0%
Biogened
Market Cap: zł53.1m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł21.60
7D
4.9%
1Y
-6.9%
Genomed Spólka Akcyjna
Market Cap: zł40.4m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł30.60
7D
27.5%
1Y
11.7%
Pure Biologics
Market Cap: zł33.4m
A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.
PUR
zł4.09
7D
10.5%
1Y
-75.9%
Medicofarma Biotech
Market Cap: zł26.0m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.38
7D
-13.0%
1Y
-9.0%
Stem Cells Spin
Market Cap: zł17.5m
Operates as a biotechnology company in Poland.
SCS
zł0.42
7D
2.9%
1Y
96.3%
genXone
Market Cap: zł13.5m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł4.10
7D
-1.2%
1Y
-40.9%
Green Zebras Spolka Akcyjna
Market Cap: zł12.9m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł9.70
7D
-1.0%
1Y
-27.6%
Cannabis Poland
Market Cap: zł10.8m
Operates in the medical cannabis industry in Poland.
CBD
zł0.22
7D
11.4%
1Y
-37.2%
Labocanna
Market Cap: zł4.2m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.20
7D
5.3%
1Y
-41.0%
Vinci Gen
Market Cap: zł3.3m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.30
7D
1.3%
1Y
-38.8%